XOR Risk Variants Drive Diabetic Kidney Disease

Overview

Journal Nat Metab

Publisher Springer Nature

Specialty Endocrinology

Date 2023 Apr 6

PMID 37024753

Authors

Ke Zhu

Jochen Reiser

Affiliations

Soon will be listed here.

References

Reidy K, Kang H, Hostetter T, Susztak K . Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014; 124(6):2333-40. PMC: 4089448. DOI: 10.1172/JCI72271. View

Alicic R, Rooney M, Tuttle K . Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017; 12(12):2032-2045. PMC: 5718284. DOI: 10.2215/CJN.11491116. View

Susztak K, Raff A, Schiffer M, Bottinger E . Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes. 2005; 55(1):225-33. View

Jha J, Banal C, Chow B, Cooper M, Jandeleit-Dahm K . Diabetes and Kidney Disease: Role of Oxidative Stress. Antioxid Redox Signal. 2016; 25(12):657-684. PMC: 5069735. DOI: 10.1089/ars.2016.6664. View

Polito L, Bortolotti M, Battelli M, Bolognesi A . Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?. Pharmacol Res. 2022; 184:106407. DOI: 10.1016/j.phrs.2022.106407. View

Qi Z, Fujita H, Jin J, Davis L, Wang Y, Fogo A . Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes. 2005; 54(9):2628-37. DOI: 10.2337/diabetes.54.9.2628. View

Kottaisamy C, Raj D, Kumar V, Sankaran U . Experimental animal models for diabetes and its related complications-a review. Lab Anim Res. 2021; 37(1):23. PMC: 8385906. DOI: 10.1186/s42826-021-00101-4. View

Ohtsubo T, Matsumura K, Sakagami K, Fujii K, Tsuruya K, Noguchi H . Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules. Hypertension. 2009; 54(4):868-76. PMC: 3773720. DOI: 10.1161/HYPERTENSIONAHA.109.135152. View

Huber R, Pietsch D, Panterodt T, Brand K . Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage. Cell Signal. 2012; 24(6):1287-96. DOI: 10.1016/j.cellsig.2012.02.007. View

10.

Zhang J, Li Y, Shan K, Wang L, Qiu W, Lu Y . Sublytic C5b-9 induces IL-6 and TGF-β1 production by glomerular mesangial cells in rat Thy-1 nephritis through p300-mediated C/EBPβ acetylation. FASEB J. 2013; 28(3):1511-25. DOI: 10.1096/fj.13-242693. View

11.

Herbelin A, Urena P, Nguyen A, Zingraff J, Descamps-Latscha B . Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991; 39(5):954-60. DOI: 10.1038/ki.1991.120. View

12.

Theilade S, Lyngbaek S, Hansen T, Eugen-Olsen J, Fenger M, Rossing P . Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes. J Intern Med. 2014; 277(3):362-371. DOI: 10.1111/joim.12269. View

13.

Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J . Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011; 17(8):952-60. PMC: 4089394. DOI: 10.1038/nm.2411. View